A total of four days of full immersion in the world of ASA to focus on the new devices - M-Hi and HIRO – and to analyse the biological effects of Hilterapia®: these were the key points of the two ASA Partners Meetings organised in February for our Italian and European partners with the aim of consolidating relations with dealers.
In the name of “teamwork” and of sharing, the two meetings were attended by more than 60 people called upon to “pool” their experiences and to discuss the unique features of the various geographical areas. The same format:
Cutting edge Therapeutic Solutions, but not only:
“during the Meetings, particular attention was paid to the state of the art of Research, underlining what has been implemented to achieve the EU MDR certification – issued by TÜV Sud in April 2023, ed. – and during the development and execution phase to continue to support ASA technologies by means of reliable validations from all over the world” Davide Travalin, ASA Clinical Manager tells us.
The positive feedback from the participants decreed the success of the initiatives which, as Alberto Zaghetto, Area Manager Italia tells us
“were organised also in order to stimulate the sales force, by providing additional indications and useful information for assisting their daily work. Tangible support aimed at further strengthening our partners”.
Carlo Marchesini, Marketing Manager, gives a similar assessment, underlining how
“particularly as concerns Italy, this meeting represented a unique occasion to meet up and to understand where to reinforce our company’s involvement. We certainly have margin for improvement to put in place and this meeting allowed us to understand how to intervene”.
Roberto Terruzzi, Senior Export Manager, clarifies:
“At last, a meeting with all our European partners! Direct discussions favour collecting very useful information for our further growth, even in countries where we have been operating for some time already”.
“Undoubtedly, compared to the past, when the presentation of new products often coincided with industry fairs, these events allowed giving proper consideration and emphasis to the launch of the two new entries. But that's not all. These meetings gave us the opportunity to showcase, discuss and allow appreciation of the details which often make the difference in the ASA products, demonstrating the company’s keen attention towards the customer’s and the patient’s requirements”, Silvia Vitulo, ASA Product Specialist states.
The strategy to involve various corporate roles in the presentation was also a winning one: “A choice – Vitulo concludes –that demonstrates how ASA is the result of mixing many types of specific skills to support our commercial partners”.
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.